“Therapeutic Apheresis:

Introduction to the Ultimate Blood Makeover”

 

      Wael Ibrahim, MD, PhD​

Assistant Professor, Pathology

Department of Laboratory and Pathology

University of Kentucky

 

Thursday, June 18, 2026

12:00 – 1:00pm

 

In-Person MS 147 or Zoom: 

 https://us06web.zoom.us/j/87832764787?pwd=Rgj3iqV6y29XzBe783LTI1Y8Nvwt5g.1

 

 

 

Please sign-in with first, last name and credentials

 

At the completion of this lecture attendees should be able to:

 

•Define therapeutic apheresis

•Discuss the different apheresis modalities

•Describe its clinical applications

•Recognize how do we serve our patients at UK

•Identify future opportunities

 

Disclosure of Financial Interest Summary to Learners

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months.  An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

 

None of the planners, faculty, and others in control of educational content for this educational activity have a relevant financial relationship(s) to disclose with ineligible companies.

 

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include a discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation

 

 

 

Session date: 
06/18/2026 - 12:30pm EDT to 07/23/2026 - 10:59pm EDT
Location: 
MS 147
800 Rose Street
Lexington, KY 40536
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Live activity is designated for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 

  • 1.00 Participation
    UK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.
Please login or register to take this course.
Faculty List: 
Speaker(s)

Wael Ibrahim, MD, PhD

has no relevant financial relationships to disclose at this time.